Jack E. Stover
CIK: 0001203603
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 21, 2026PFSA
Profusa, Inc.
Other(J)Direct32K shares- - Aug 21, 2026PFSA
Profusa, Inc.
Other(J)Indirect302K shares- - Aug 12, 2026PFSA
Profusa, Inc.
Conversion(C)Indirect302K shares at avg. $4.28$1.3M - Jul 9, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
14.2K shares- - May 4, 2026PFSA
Profusa, Inc.
Purchase(P)IndirectConvertible Promissory Note
0 shares at avg. $1869796.00- - Mar 8, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
33.4K shares- - Jan 26, 2026PFSA
Profusa, Inc.
Other(J)Direct553.7K shares- - Jan 26, 2026PFSA
Profusa, Inc.
Award(A)DirectStock Options
221.8K shares- - Jan 26, 2026PFSA
Profusa, Inc.
Award(A)DirectStock Options
52.9K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
Award(A)Direct6.2K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to purchase)
11.5K shares- - Jun 19, 2025TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to purchase)
23K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 |  PFSA Profusa, Inc. | Other(J) | 32,018 | - | $0 | Direct |
| Aug 21, 2026 | PFSA Profusa, Inc. | Other(J) | 301,991 | - | $0 | Indirect |
| Aug 12, 2026 | PFSA Profusa, Inc. | Conversion(C) | 301,991 | $4.28 | $1,292,521 | Indirect |
| Jul 9, 2026 |  TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 14,150 | - | - | Direct |
| May 4, 2026 | PFSA Profusa, Inc. | Purchase(P) Convertible Promissory Note | 0 | $1869796.00 | - | Indirect |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 33,435 | - | - | Direct |
| Jan 26, 2026 | PFSA Profusa, Inc. | Other(J) | 553,665 | - | $0 | Direct |
| Jan 26, 2026 | PFSA Profusa, Inc. | Award(A) Stock Options | 221,794 | - | - | Direct |
| Jan 26, 2026 | PFSA Profusa, Inc. | Award(A) Stock Options | 52,866 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) | 6,157 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to purchase) | 11,530 | - | - | Direct |
| Jun 19, 2025 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to purchase) | 23,000 | - | - | Direct |
1-12 of 12 transactions
About STOVER JACK E
STOVER JACK E (SEC CIK 0001203603) files insider reports with the SEC as Chief Executive Officer of Profusa, Inc. (PFSA), Director of Traws Pharma, Inc. (TRAW) and Director of Transcode Therapeutics, Inc. (RNAZ).
Signal8 holds 11 ownership filings by STOVER JACK E (1 Form 3, 10 Form 4), filed between Jun 23, 2025 and Sep 4, 2026. Those filings report 12 transactions, from Jun 19, 2025 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on STOVER JACK E's filings is in BERKELEY, CA.
Recent filings by STOVER JACK E
- Aug 21, 2026: Other transactions of PFSA shares (2 lines, Form 4, code J).
- Aug 12, 2026: Conversion of PFSA shares (Form 4, code C).
- Jul 9, 2026: Grant or award of TRAW derivative securities (Form 4, code A).
- May 4, 2026: Open-market purchase of PFSA derivative securities (Form 4, code P).
- Mar 8, 2026: Grant or award of TRAW derivative securities (Form 4, code A).
Other insiders filing for Profusa, Inc. (PFSA)
- Knechtel Fred S., Chief Financial Officer
- HRT FINANCIAL LP, 10% Owner
- NorthView Sponsor I, LLC, 10% Owner
- O'Rourke Peter, Director
- Chung Lauren, Director
- Asarpota Rajesh, Director